entity

SLC16A7

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC16A7: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
3Hypotheses
2Analyses
4Outgoing
1Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (4)

TargetRelationTypeStr
h-b2ebc9b2targeted_byhypothesis1.00
ENERGY METABOLISMinvolved_inentity0.85
Neuronal glucose uptakeregulatesprocess0.70
lactate_shuttlingmodulatespathway0.70

Incoming (1)

SourceRelationTypeStr
h-b2ebc9b2targetshypothesis1.00

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Astrocyte-Neuron Metabolic Coupling 0.455 clinical-neurology Why do systemic anti-inflammatory drugs
Neuron-Astrocyte Metabolic Mismatch Syndrome 0.000 - How do astrocyte-neuron metabolic intera
Metabolic Reprogramming via Lactate Utilization 0.000 - Selective vulnerability of entorhinal co

Mentioning Analyses (2)

Scientific analyses that reference this entity

Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular effica

clinical neurology | 2026-04-08 | 7 hypotheses Top: 0.455

How do astrocyte-neuron metabolic interactions change during disease progression

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.541

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite th

closed · Rounds: 4 · Score: 0.79 · 2026-04-09

How do astrocyte-neuron metabolic interactions change during disease progression

closed · Rounds: 4 · Score: 0.93 · 2026-04-04

Related Research

Hypotheses and analyses mentioning SLC16A7 in their description or question text

No additional research found